Abdul Kadir H. Mohammed

Senior Professor of Biological Psychology

Linnaeus University


Abdul Kadir H. Mohammed is Senior Professor of Biological Psychology at Linnaeus University, and associated at Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
He is a past Chair of African Regional Committee of International Brain Research Organization (IBRO) and served on IBRO Executive Board.
He has been an invited lecturer at a number of universities in Africa, Europe and USA including Princeton and Harvard Medical School. He has been a visiting Professor at Baylor College of Medicine, Texas Medical Center, where he was doing research on genetic dissection of learning and memory in drosophila.
He is involved in the EU-funded Human Brain Project, in which he works in the Subproject “Ethics and Society”. He did seminal work on the impact of environmental enrichment on brain and behaviour at adulthood and during aging at Karolinska Institutet ; and leads the SAGE (Successful Aging and Enrichment) project at Linnaeus University.
Dr Mohammed has more than 100 scientific publications and has served on the Editorial Advisory Board of the Journal Behavioural Brain Research.
He has been a member of the Quality Board of EUROPLAT, a network of 32 European universities dedicated to enhancing learning and teaching of Psychology in Europe. He is a Fellow of the Linnean Society of London.

Dr Khalid Saeed

Consultant Psychiatrist

WHO


Dr Saeed is a consultant psychiatrist of more than 23 years standing, currently working as Regional advisor, Mental Health and Substance Abuse at the regional office for the Eastern Mediterranean of WHO Dr Saeed was previously working as associate Professor at the Institute of Psychiatry, WHO Collaborating Centre mental health and substance abuse at Rawalpindi, Pakistan with responsibilities for teaching, training, clinical service provision. He was also the deputy Programme Manager for the National mental health programme aimed at integration of mental health in PHC.
He was a member of WHO Expert advisory Committees on ICD-10 chapter V revision, mhGAP and mental health legislation.
He is currently coordinating the work on mental health and psychosocial support in emergencies in the region besides leading the work on scaling up mental health and strengthening public health response to the substance use problem in the region He has also extensive experience of evaluation and setting up of mental health policies, legislations treatment systems and services in countries of Eastern Mediterranean region

Stephan Bongard

Associate Professor for Psychology

Goethe-University Frankfurt


Stephan Bongard is an Associate Professor for Psychology at the Goethe-University Frankfurt, Department of Psychology. He graduated in Psychology at the Technical University Aachen.
His research interests are related to stress and emotion. In recent years he became more interested in migration and acculturation stress. He teaches psychological assessment and individual differences.

Dr. Saïd Boujraf

Professor of Biophysics

University of Fez, Morocco


Dr. Saïd Boujraf is currently a full professor of Biophysics and Clinical MRI Methods at the University of Fez, Morocco.
His main interest is in applying MRI methods for the study of brain plasticity and functional control re-organization in health and disease.
In collaboration with colleagues in Fes, he is co-leadingthe Minnesoa-Morocco Stress and Addiction research program (MIMOSA) where one of the aims is to study the impact of cannabis addiction and stress on human brain using MRI techniques including diffusion tensor imaging (DTI), BOLD-fMRI and MRI Morphometry.
Dr. Boujraf completed his studies at the faculty of Medicine, University of Brussels where he completed his Ph.D.

Kathleen T. Brady, M.D., Ph.D.

Distinguished University Professor - Vice President for Research

Medical University of South Carolina


Dr. Brady is an experienced clinical and translational researcher and has been conducting scientific investigations and clinical work in the field of addictions and psychiatric disorders for over 30 years. Her research focuses on pharmacotherapy of substance use disorders, comorbidity of psychiatric disorders and addictions (e.g., posttraumatic stress disorder and bipolar disorder), gender differences and women’s issues in addictions, and the neurobiologic connections between stress and addictions.
She has received numerous federal research grants and has published over 300 peer-reviewed journal articles and co-edited 10 books. She is the principal Investigator of MUSC’s Clinical and Translational Science Award (CTSA), Principal Investigator of the Southern Consortium Node of the NIDA-funded Clinical Trials Network and Director of MUSC’s Women’s Research Center.
Her dedication to furthering research careers has attracted a number of junior investigators and clinicians. She has served at the President of the Association for Medical Education and Research in Substance Use Disorders (AMERSA), the American Academy of Addiction Psychiatry (AAAP) and is currently the President of the International Society of Addiction Medicine (ISAM).

Dr. Gilberto Gerra

Professor on Neurology
and Addiction Medicine

Italy


Gilberto Gerra, born on 24 May 1956, Parma - Italy
- Medical Doctor Degree at the University of Parma in 1981
- Specialist in Internal Medicine 1986
- Specialist in Endocrinology 1989
Professor at numerous universities in Italy, on Neurology and Addiction Medicine.
Consultant to the ministries (Ministry of Health, Ministry of Interior, and Ministry of Social Affairs) in the field of substance use disorders prevention and treatment in Italy.
- 1993 - 2002 Director of the Addiction Research Centre of Parma
- 1995 - 2002 Director of the Drug Addiction Treatment Centre in Parma
- 2003 - 2006 Director of the National Observatory on Drugs, at the Prime Minister Office, Rome, Italy
- 2004 - 2007 Member of International Narcotics Control Board (INCB) at the United Nations, Vienna
- 2007 - Present Chief of Drug Prevention and Health Branch, Division for Operations, United Nations Office on Drugs and Crime, Vienna. He is Author and/or Co Author of many articles in the field of psychobiology of substance abuse, psychoneuroendocrinology and clinical pharmacology (136 articles on scientific peer reviewed journals).
- Member of the College on Problem of Drug Dependence (CPDD)
- Referee of many scientific journals in the field of addiction and clinical pharmacology.

Scott Sherman

Professor of Population Health

NYU School of Medicine


Professor of Population Health, Medicine and Psychiatry & Co-Chief, Section on Tobacco,
Alcohol and Drug Use, NYU School of Medicine
Dr. Sherman received his medical degree from NYU School of Medicine and completed a Masters of Public Health degree in Epidemiology and Biostatistics at Boston University School of Public Health.
He is a practicing physician in internal medicine and sees patients at the Veterans Health Administration (VA) in New York. He has also been very active nationally in tobacco control within the VA, including being chair of the group advising the VA on tobacco control from 2002-2006 and co-lead author on the VA’s national tobacco control guidelines. The policies that he helped to put in place within the VA dramatically increased the delivery of evidence-based smoking cessation treatment and have been responsible for hundreds of thousands of additional people quitting smoking.
Dr. Sherman’s research studies have focused on how to redesign health care systems to better help people quit smoking. He is particularly focused on population health studies, which examine the effectiveness of interventions in routine practice, as well as how to disseminate and implement them. His recent studies have examined the impact of a telephone care coordination program for smoking in primary care and in mental health and also the use a proactive outreach approach to smokers.
He is studying the use of text messaging to support smoking cessation and behavioral economic strategies to help increase the use of treatment. He has over 100 peer-reviewed publications in scientific journals.
He is currently leading five major grants, with funding from the National Institutes of Health, the Veterans Health Administration and foundations.
2020 AMECA Congress